<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001807214</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001426800</issuerCik>
<issuerName>Assembly Biosciences, Inc.</issuerName>
<secFileNumber>001-35005</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">331 Oyster Point Blvd.</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Fourth Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">South San Francisco</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">94080</zipCode>
</issuerAddress>
<issuerContactPhone>833-509-4583</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Jason Okazaki</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
<relationshipToIssuer>Director</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1 New York Plaza</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">38th Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10004</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>11827</noOfUnitsSold>
<aggregateMarketValue>12866.59</aggregateMarketValue>
<noOfUnitsOutstanding>52121309</noOfUnitsOutstanding>
<approxSaleDate>08/02/2023</approxSaleDate>
<securitiesExchangeName>Nasdaq</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>08/01/2023</acquiredDate>
<natureOfAcquisitionTransaction>Restricted Stock Unit Release</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Assembly Biosciences, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>11827</amountOfSecuritiesAcquired>
<paymentDate>08/02/2023</paymentDate>
<natureOfPayment>N/A</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Jason A. Okazaki</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">c/o 331 Oyster Point Blvd.</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Fourth Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">South San Francisco</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">94080</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>05/22/2023</saleDate>
<amountOfSecuritiesSold>6561</amountOfSecuritiesSold>
<grossProceeds>6825.41</grossProceeds>
</securitiesSoldInPast3Months>
<noticeSignature>
<noticeDate>08/02/2023</noticeDate>
<signature>/s/ Jason A. Okazaki</signature>
</noticeSignature>
</formData>
</edgarSubmission>
